Heparan Sulfate Proteoglycans in the Basement Membranes of the Human Placenta and Decidua

Placenta

Volumn 29, Issue 4, 2008, Pages 309-316

  Chen, C P ^a,b   Liu, S H ^a   Lee, M Y ^a   Chen, Y Y ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Agrin; Collagen XVIII; Perlecan; Placenta; Proteoglycan

Indexed keywords

AGRIN; CELL RECEPTOR; COLLAGEN TYPE 18; COLLAGEN TYPE 4; GLYCOSAMINOGLYCAN; GROWTH FACTOR; LAMININ; PERLECAN; PROTEOHEPARAN SULFATE; SCLEROPROTEIN;

ARTICLE; BASEMENT MEMBRANE; COVALENT BOND; DECIDUA; EXTRACELLULAR MATRIX; HUMAN; MORPHOGENESIS; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STROMA; TISSUE STRUCTURE; TROPHOBLAST;

AGRIN; BASEMENT MEMBRANE; COLLAGEN; DECIDUA; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; PLACENTA; PREGNANCY;

EID: 40949100355     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.01.002     Document Type: Article

References (78)

1. Timpl R., and Brown J.C. Supramolecular assembly of basement membranes. Bioessays 18 (1996) 123-132
2. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol 8 (1996) 618-624
3. Lindahl U., Backstrom G., Thunberg L., and Leder I.G. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A 77 (1980) 6551-6555
4. Murray R.K., and Keeley F.W. The extracellular matrix. In: Murray R.K., Granner D.K., Mayes P.A., and Rodwell V.W. (Eds). Harper's biochemistry (2000), Appleton and Lange, Stamford, Connecticut 695-714
5. Iozzo R.V. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108 (2001) 165-167
6. Crescimanno C., Marzioni D., Paradinas F.J., Schrurs B., Muhlhauser J., Todros T., et al. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J Pathol 189 (1999) 600-608
7. Jokimaa V.I., Kujari H.P., Ekholm E.M., Inki P.L., and Anttila L. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol 183 (2000) 1495-1498
8. Jokimaa V., Inki P., Kujari H., Hirvonen O., Ekholm E., and Anttila L. Expression of syndecan-1 in human placenta and decidua. Placenta 19 (1998) 157-163
9. Ishiguro K., Kadomatsu K., Kojima T., Muramatsu H., Nakamura E., Ito M., et al. Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth. Dev Dyn 219 (2000) 539-544
10. Khan S., Blackburn M., Mao D.L., Huber R., Schlessinger D., and Fant M. Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast. Histol Histopathol 16 (2001) 71-78
11. Chen C.P., and Aplin J.D. Placental extracellular matrix: gene expression, deposition by placental fibroblasts and the effect of oxygen. Placenta 24 (2003) 316-325
12. Costell M., Gustafsson E., Aszodi A., Morgelin M., Bloch W., Hunziker E., et al. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147 (1999) 1109-1122
13. Murdoch A.D., Liu B., Schwarting R., Tuan R.S., and Iozzo R.V. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 42 (1994) 239-249
14. Dolan M., Horchar T., Rigatti B., and Hassell J.R. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. J Biol Chem 272 (1997) 4316-4322
15. Kallunki P., Eddy R.L., Byers M.G., Kestila M., Shows T.B., and Tryggvason K. Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1→p35 and identification of a BamHI restriction fragment length polymorphism. Genomics 11 (1991) 389-396
16. Iozzo R.V. Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 6 (2005) 646-656
17. Bix G., Fu J., Gonzalez E.M., Macro L., Barker A., Campbell S., et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol 166 (2004) 97-109
18. Mongiat M., Sweeney S.M., San Antonio J.D., Fu J., and Iozzo R.V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 278 (2003) 4238-4249
19. Bix G., Castello R., Burrows M., Zoeller J.J., Weech M., Iozzo R.A., et al. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J Natl Cancer Inst 98 (2006) 1634-1646
20. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R., and Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet 23 (1999) 354-358
21. Rodgers K.D., Sasaki T., Aszodi A., and Jacenko O. Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome. Hum Mol Genet 16 (2007) 515-528
22. Miettinen A., Stow J.L., Mentone S., and Farquhar M.G. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 163 (1986) 1064-1084
23. Gallai M., Kovalszky I., Knittel T., Neubauer K., Armbrust T., and Ramadori G. Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells. Am J Pathol 148 (1996) 1463-1471
24. Segev A., Nili N., and Strauss B.H. The role of perlecan in arterial injury and angiogenesis. Cardiovasc Res 63 (2004) 603-610
25. Zhou Z., Wang J., Cao R., Morita H., Soininen R., Chan K.M., et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 64 (2004) 4699-4702
26. Dziadek M., Fujiwara S., Paulsson M., and Timpl R. Immunological characterization of basement membrane types of heparan sulfate proteoglycan. EMBO J 4 (1985) 905-912
27. Carson D.D., Tang J.P., and Julian J. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol 155 (1993) 97-106
28. Smith S.E., French M.M., Julian J., Paria B.C., Dey S.K., and Carson D.D. Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation. Dev Biol 184 (1997) 38-47
29. Slater M., and Murphy C.R. Chondroitin sulphate and heparan sulfate proteoglycan are sequentially expressed in the uterine extracellular matrix during early pregnancy in the rat. Matrix Biol 18 (1999) 125-131
30. Rohde L.H., Janatpore M.J., McMaster M.T., Fisher S., Zhou Y., Lim K.H., et al. Complementary expression of HIP, a cell-surface heparan sulfate binding protein, and perlecan at the human fetal-maternal interface. Biol Reprod 58 (1998) 1075-1083
31. Rohde L.H., Julian J., Babaknia A., and Carson D.D. Cell surface expression of HIP, a novel heparin/heparan sulfate binding protein, of human uterine epithelial cells and cell lines. J Biol Chem 271 (1996) 11824-11830
32. Fontana V., Choren V., Vauthay L., Calvo J.C., Calvo L., and Cameo M. Exogenous interferon-gamma alters murine inner cell mass and trophoblast development. Effect on the expression of ErbB1, ErbB4 and heparan sulfate proteoglycan (perlecan). Reproduction 128 (2004) 717-725
33. Farach M.C., Tang J.P., Decker G.L., and Carson D.D. Heparin/heparan sulfate is involved in attachment and spreading of mouse embryos in vitro. Dev Biol 123 (1987) 401-410
34. Gonzalez E.M., Reed C.C., Bix G., Fu J., Zhang Y., Gopalakrishnan B., et al. BMP-1/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem 280 (2005) 7080-7087
35. Carson D.D., Bagchi I., Dey S.K., Enders A.C., Fazleabas A.T., Lessey B.A., et al. Embryo implantation. Dev Biol 223 (2000) 217-237
36. Yang W.C., Su T.H., Yang Y.C., Chang S.C., Chen C.Y., and Chen C.P. Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta 26 (2005) 780-788
37. Chen C.P., Chang S.C., and Vivian Yang W.C. High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Placenta 28 (2007) 97-106
38. Vogl-Willis C.A., and Edwards I.J. High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Biochim Biophys Acta 1672 (2004) 36-45
39. Rupp F., Ozcelik T., Linial M., Peterson K., Francke U., and Scheller R. Structure and chromosomal localization of the mammalian agrin gene. J Neurosci 12 (1992) 3535-3544
40. Groffen A.J., Buskens C.A., van Kuppevelt T.H., Veerkamp J.H., Monnens L.A., and van den Heuvel L.P. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 254 (1998) 123-128
41. Denzer A.J., Gesemann M., Schumacher B., and Ruegg M.A. An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. J Cell Biol 131 (1995) 1547-1560
42. Denzer A.J., Brandenberger R., Gesemann M., Chiquet M., and Ruegg M.A. Agrin binds to the nerve-muscle basal lamina via laminin. J Cell Biol 137 (1997) 671-683
43. Burgess R.W., Nguyen Q.T., Son Y.J., Lichtman J.W., and Sanes J.R. Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron 23 (1999) 33-44
44. Burgess R.W., Skarnes W.C., and Sanes J.R. Agrin isoforms with distinct amino termini: differential expression, localization, and function. J Cell Biol 151 (2000) 41-52
45. Yang J.F., Cao G., Koirala S., Reddy L.V., and Ko C.P. Schwann cells express active agrin and enhance aggregation of acetylcholine receptors on muscle fibers. J Neurosci 21 (2001) 9572-9584
46. Lin W., Burgess R.W., Dominguez B., Pfaff S.L., Sanes J.R., and Lee K.F. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410 (2001) 1057-1064
47. Gautam M., Noakes P.G., Moscoso L., Rupp F., Scheller R.H., Merlie J.P., et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85 (1996) 525-535
48. Tsen G., Halfter W., Kroger S., and Cole G.J. Agrin is a heparan sulfate proteoglycan. J Biol Chem 270 (1995) 3392-3399
49. Bezakova G., and Ruegg M.A. New insights into the roles of agrin. Nat Rev Mol Cell Biol 4 (2003) 295-308
50. Raats C.J., Bakker M.A., Hoch W., Tamboer W.P., Groffen A.J., van den Heuvel L.P., et al. Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 273 (1998) 17832-17838
51. Raats C.J., Van Den Born J., and Berden J.H. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int 57 (2000) 385-400
52. Tatrai P., Dudas J., Batmunkh E., Mathe M., Zalatnai A., Schaff Z., et al. Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab Invest 86 (2006) 1149-1160
53. Shaw A.S., and Allen P.M. Kissing cousins: immunological and neurological synapses. Nat Immunol 2 (2001) 575-576
54. Vuadens F., Benay C., Crettaz D., Gallot D., Sapin V., Schneider P., et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 3 (2003) 1521-1525
55. Halfter W., Dong S., Schurer B., and Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 273 (1998) 25404-25412
56. Oh S.P., Warman M.L., Seldin M.F., Cheng S.D., Knoll J.H., Timmons S., et al. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19 (1994) 494-499
57. Rehn M., and Pihlajaniemi T. Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci U S A 91 (1994) 4234-4238
58. Sasaki T., Fukai N., Mann K., Gohring W., Olsen B.R., and Timpl R. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J 17 (1998) 4249-4256
59. Marneros A.G., and Olsen B.R. Physiological role of collagen XVIII and endostatin. Faseb J 19 (2005) 716-728
60. Rehn M., Hintikka E., and Pihlajaniemi T. Characterization of the mouse gene for the alpha1 chain of type XVIII collagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters. Genomics 32 (1996) 436-446
61. Saarela J., Rehn M., Oikarinen A., Autio-Harmainen H., and Pihlajaniemi T. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 153 (1998) 611-626
62. Suzuki O.T., Sertie A.L., Der Kaloustian V.M., Kok F., Carpenter M., Murray J., et al. Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am J Hum Genet 71 (2002) 1320-1329
63. Ferreras M., Felbor U., Lenhard T., Olsen B.R., and Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486 (2000) 247-251
64. Lin H.C., Chang J.H., Jain S., Gabison E.E., Kure T., Kato T., et al. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci 42 (2001) 2517-2524
65. Wen W., Moses M.A., Wiederschain D., Arbiser J.L., and Folkman J. The generation of endostatin is mediated by elastase. Cancer Res 59 (1999) 6052-6056
66. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
67. Oh S.P., Kamagata Y., Muragaki Y., Timmons S., Ooshima A., and Olsen B.R. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc Natl Acad Sci U S A 91 (1994) 4229-4233
68. Dong S., Cole G.J., and Halfter W. Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites. J Biol Chem 278 (2003) 1700-1707
69. Fukai N., Eklund L., Marneros A.G., Oh S.P., Keene D.R., Tamarkin L., et al. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J 21 (2002) 1535-1544
70. Ylikarppa R., Eklund L., Sormunen R., Kontiola A.I., Utriainen A., Maatta M., et al. Lack of type XVIII collagen results in anterior ocular defects. Faseb J 17 (2003) 2257-2259
71. Marneros A.G., Keene D.R., Hansen U., Fukai N., Moulton K., Goletz P.L., et al. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J 23 (2004) 89-99
72. Utriainen A., Sormunen R., Kettunen M., Carvalhaes L.S., Sajanti E., Eklund L., et al. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum Mol Genet 13 (2004) 2089-2099
73. Pollheimer J., Bauer S., Huber A., Husslein P., Aplin J.D., and Knofler M. Expression pattern of collagen XVIII and its cleavage product, the angiogenesis inhibitor endostatin, at the fetal-maternal interface. Placenta 25 (2004) 770-779
74. Pollheimer J., Husslein P., and Knofler M. Invasive trophoblasts generate regulatory collagen XVIII cleavage products. Placenta 26 Suppl. A (2005) S42-S45
75. Hirtenlehner K., Pollheimer J., Lichtenberger C., Wolschek M.F., Zeisler H., Husslein P., et al. Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women. J Soc Gynecol Investig 10 (2003) 412-417
76. Athanassiades A., Hamilton G.S., and Lala P.K. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod 59 (1998) 643-654
77. Lash G.E., Warren A.Y., Underwood S., and Baker P.N. Vascular endothelial growth factor is a chemoattractant for trophoblast cells. Placenta 24 (2003) 549-556
78. Kim Y.M., Hwang S., Kim Y.M., Pyun B.J., Kim T.Y., Lee S.T., et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277 (2002) 27872-27879